ZD1839 ('Iressa'), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model. (Q36623819)
Jump to navigation
Jump to search
scientific article published on April 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ZD1839 ('Iressa'), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model. |
scientific article published on April 2002 |
Statements
ZD1839 ('Iressa'), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model (English)
I J Stratford
1 April 2002
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference